BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 11266782)

  • 1. Transplantation and the CD28/CTLA4/B7 pathway.
    Alegre M; Fallarino F; Zhou P; Frauwirth K; Thistlethwaite J; Newell K; Gajewski T; Bluestone J
    Transplant Proc; 2001; 33(1-2):209-11. PubMed ID: 11266782
    [No Abstract]   [Full Text] [Related]  

  • 2. Could expression of co-stimulatory molecules on B-PBL condition the acceptance or rejection of human liver grafts?
    Minguela A; Sánchez-Bueno F; Marín L; Miras M; Pons JA; Muro M; Torío A; García-Alonso AM; Robles R; Parrilla P; Ramirez P; Alvarez-López MR
    Transplant Proc; 2001; 33(1-2):1384-5. PubMed ID: 11267338
    [No Abstract]   [Full Text] [Related]  

  • 3. New protein steals the show as 'costimulator' of T cells.
    Cohen J
    Science; 1993 Nov; 262(5135):844-5. PubMed ID: 7694360
    [No Abstract]   [Full Text] [Related]  

  • 4. CD80 (B7-1) and CD86 (B7-2): potential targets for immunotherapy?
    van Gool SW; Barcy S; Devos S; Vandenberghe P; Ceuppens JL; Thielemans K; de Boer M
    Res Immunol; 1995; 146(3):183-96. PubMed ID: 8525052
    [No Abstract]   [Full Text] [Related]  

  • 5. Costimulatory regulation of T cell function.
    Chambers CA; Allison JP
    Curr Opin Cell Biol; 1999 Apr; 11(2):203-10. PubMed ID: 10209159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of costimulatory molecules on dendritic cells: implications for tolerance induction.
    Luke PP; Thomson AW
    Transplant Proc; 2001; 33(1-2):507-8. PubMed ID: 11266929
    [No Abstract]   [Full Text] [Related]  

  • 7. CD28/CTLA-4 and CD80/CD86 costimulatory molecules are mainly involved in acceptance or rejection of human liver transplant.
    Minguela A; Marín L; Torío A; Muro M; García-Alonso AM; Moya-Quiles MR; Sánchez-Bueno F; Parrilla P; Alvarez-López MR
    Hum Immunol; 2000 Jul; 61(7):658-69. PubMed ID: 10880736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of the B7-CD28 pathway by CTLA4-Ig counteracts rejection and prolongs survival in small bowel transplantation.
    Kurlberg G; Haglind E; Schön K; Törnqvist H; Lycke N
    Scand J Immunol; 2000 Mar; 51(3):224-30. PubMed ID: 10736090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The complexities of T-cell co-stimulation: CD28 and beyond.
    Sperling AI; Bluestone JA
    Immunol Rev; 1996 Oct; 153():155-82. PubMed ID: 9010723
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative strategies to induce long-term graft acceptance in fully allogeneic renal versus cardiac allograft models by CD28-B7 T cell costimulatory blockade: role of thymus and spleen.
    Schaub M; Stadlbauer TH; Chandraker A; Vella JP; Turka LA; Sayegh MH
    J Am Soc Nephrol; 1998 May; 9(5):891-8. PubMed ID: 9596088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B7-CTLA4 interaction promotes cognate destruction of tumor cells by cytotoxic T lymphocytes in vivo.
    Bai XF; Liu J; May KF; Guo Y; Zheng P; Liu Y
    Blood; 2002 Apr; 99(8):2880-9. PubMed ID: 11929778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Yin and Yang of T cell costimulation.
    Allison JP; Krummel MF
    Science; 1995 Nov; 270(5238):932-3. PubMed ID: 7481795
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of the B7-CD28/CTLA-4 pathway in autoimmune disease.
    Chang TT; Kuchroo VK; Sharpe AH
    Curr Dir Autoimmun; 2002; 5():113-30. PubMed ID: 11826754
    [No Abstract]   [Full Text] [Related]  

  • 14. B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4.
    Mandelbrot DA; Oosterwegel MA; Shimizu K; Yamada A; Freeman GJ; Mitchell RN; Sayegh MH; Sharpe AH
    J Clin Invest; 2001 Apr; 107(7):881-7. PubMed ID: 11285307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD28/B7 costimulation: a review.
    Greenfield EA; Nguyen KA; Kuchroo VK
    Crit Rev Immunol; 1998; 18(5):389-418. PubMed ID: 9784967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28.
    Lin H; Rathmell JC; Gray GS; Thompson CB; Leiden JM; Alegre ML
    J Exp Med; 1998 Jul; 188(1):199-204. PubMed ID: 9653096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative effect of CTLA-4 on induction of T-cell immunity in vivo to B7-1+, but not B7-2+, murine myelogenous leukemia.
    LaBelle JL; Hanke CA; Blazar BR; Truitt RL
    Blood; 2002 Mar; 99(6):2146-53. PubMed ID: 11877291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways.
    Woodward JE; Qin L; Chavin KD; Lin J; Tono T; Ding Y; Linsley PS; Bromberg JS; Baliga P
    Transplantation; 1996 Oct; 62(7):1011-8. PubMed ID: 8878397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes.
    Salomon B; Lenschow DJ; Rhee L; Ashourian N; Singh B; Sharpe A; Bluestone JA
    Immunity; 2000 Apr; 12(4):431-40. PubMed ID: 10795741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of CTLA-4 in the regulation and initiation of T-cell responses.
    Chambers CA; Krummel MF; Boitel B; Hurwitz A; Sullivan TJ; Fournier S; Cassell D; Brunner M; Allison JP
    Immunol Rev; 1996 Oct; 153():27-46. PubMed ID: 9010718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.